Literature DB >> 9570769

Thylacine 1 is expressed segmentally within the paraxial mesoderm of the Xenopus embryo and interacts with the Notch pathway.

D B Sparrow1, W C Jen, S Kotecha, N Towers, C Kintner, T J Mohun.   

Abstract

The presomitic mesoderm of vertebrates undergoes a process of segmentation in which cell-cell interactions mediated by the Notch family of receptors and their associated ligands are involved. The vertebrate homologues of Drosophila &Dgr ; are expressed in a dynamic, segmental pattern within the presomitic mesoderm, and alterations in the function of these genes leads to a perturbed pattern of somite segmentation. In this study we have characterised Thylacine 1 which encodes a basic helix-loop-helix class transcription activator. Expression of Thylacine is restricted to the presomitic mesoderm, localising to the anterior half of several somitomeres in register with domains of X-Delta-2 expression. Ectopic expression of Thylacine in embryos causes segmentation defects similar to those seen in embryos in which Notch signalling is altered, and these embryos also show severe disruption in the expression patterns of the marker genes X-Delta-2 and X-ESR5 within the presomitic mesoderm. Finally, the expression of Thylacine is altered in embryos when Notch signalling is perturbed. These observations suggest strongly that Thylacine 1 has a role in the segmentation pathway of the Xenopus embryo, by interacting with the Notch signalling pathway.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9570769     DOI: 10.1242/dev.125.11.2041

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  9 in total

1.  Periodic repression of Notch pathway genes governs the segmentation of Xenopus embryos.

Authors:  W C Jen; V Gawantka; N Pollet; C Niehrs; C Kintner
Journal:  Genes Dev       Date:  1999-06-01       Impact factor: 11.361

2.  The bHLH regulator pMesogenin1 is required for maturation and segmentation of paraxial mesoderm.

Authors:  J K Yoon; B Wold
Journal:  Genes Dev       Date:  2000-12-15       Impact factor: 11.361

3.  Expression of the forkhead transcription factor FoxN4 in progenitor cells in the developing Xenopus laevis retina and brain.

Authors:  Lisa E Kelly; Srivamsi Nekkalapudi; Heithem M El-Hodiri
Journal:  Gene Expr Patterns       Date:  2006-10-07       Impact factor: 1.224

4.  Characterization and expression of a presomitic mesoderm-specific mespo gene in zebrafish.

Authors:  Kyeong-Won Yoo; Cheol-Hee Kim; Hae-Chul Park; Seok-Hyung Kim; Hyung-Seok Kim; Sung-Kook Hong; Sangtae Han; Myungchull Rhee; Tae-Lin Huh
Journal:  Dev Genes Evol       Date:  2003-04-01       Impact factor: 0.900

5.  Target specificities of Drosophila enhancer of split basic helix-loop-helix proteins.

Authors:  B H Jennings; D M Tyler; S J Bray
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

6.  Mutated MESP2 causes spondylocostal dysostosis in humans.

Authors:  Neil V Whittock; Duncan B Sparrow; Merridee A Wouters; David Sillence; Sian Ellard; Sally L Dunwoodie; Peter D Turnpenny
Journal:  Am J Hum Genet       Date:  2004-04-30       Impact factor: 11.025

7.  Retinoic acid regulation of the Mesp-Ripply feedback loop during vertebrate segmental patterning.

Authors:  Tanya A Moreno; Roberto Jappelli; Juan Carlos Izpisúa Belmonte; Chris Kintner
Journal:  Dev Biol       Date:  2008-01-03       Impact factor: 3.582

8.  In vivo T-box transcription factor profiling reveals joint regulation of embryonic neuromesodermal bipotency.

Authors:  George E Gentsch; Nick D L Owens; Stephen R Martin; Paul Piccinelli; Tiago Faial; Matthew W B Trotter; Michael J Gilchrist; James C Smith
Journal:  Cell Rep       Date:  2013-09-19       Impact factor: 9.423

9.  A gene regulation network controlled by Celf1 protein-rbpj mRNA interaction in Xenopus somite segmentation.

Authors:  Marie Cibois; Carole Gautier-Courteille; Laurent Kodjabachian; Luc Paillard
Journal:  Biol Open       Date:  2013-08-30       Impact factor: 2.422

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.